BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 36229592)

  • 1. Treatment landscape of advanced high-grade neuroendocrine neoplasms.
    Alheraki SZ; Almquist DR; Starr JS; Halfdanarson TR; Sonbol MB
    Clin Adv Hematol Oncol; 2023 Jan; 21(1):16-26. PubMed ID: 36638352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Fazio N; Milione M
    Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An innovative diagnosis in gastrointestinal neuroendocrine neoplasms using Wax-Physisorption-Kinetics-based FTIR Imaging.
    Chen YT; Huang PY; Wang JY; Lee YC; Chai CY
    Sci Rep; 2022 Oct; 12(1):17168. PubMed ID: 36229592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenite Regulates Prolongation of Glycan Residues of Membrane Glycoprotein: A Pivotal Study via Wax Physisorption Kinetics and FTIR Imaging.
    Lee CH; Hsu CY; Huang PY; Chen CI; Lee YC; Yu HS
    Int J Mol Sci; 2016 Mar; 17(3):427. PubMed ID: 27011183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
    Klöppel G
    Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks.
    Peixoto A; Relvas-Santos M; Azevedo R; Santos LL; Ferreira JA
    Front Oncol; 2019; 9():380. PubMed ID: 31157165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation and metastases.
    Josic D; Martinovic T; Pavelic K
    Electrophoresis; 2019 Jan; 40(1):140-150. PubMed ID: 30246896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review.
    Fornasier G; Francescon S; Baldo P
    Adv Ther; 2018 Oct; 35(10):1497-1509. PubMed ID: 30218345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.
    Wilson FR; Coombes ME; Wylie Q; Yurchenko M; Brezden-Masley C; Hutton B; Skidmore B; Cameron C
    Syst Rev; 2017 Oct; 6(1):196. PubMed ID: 29017563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Glycosylation in Cancer: A Novel Molecular Mechanism Controlling Metastasis.
    Magalhães A; Duarte HO; Reis CA
    Cancer Cell; 2017 Jun; 31(6):733-735. PubMed ID: 28609653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems.
    Shen C; Yin Y; Chen H; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    Oncotarget; 2017 Mar; 8(13):22123-22134. PubMed ID: 27902460
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.